Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04502758 · ClinicalTrials.gov registry record · NA

Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation

A NA study of Major Depressive Disorder and Suicidal Ideation, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04502758 is a NA study of Major Depressive Disorder and Suicidal Ideation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 80 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04502758, a NA study of Major Depressive Disorder and Suicidal Ideation, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to gather information regarding the use of a new type of transcranial magnetic stimulation (TMS) called theta burst stimulation (TBS) for suicidal ideation in adolescents with Major Depressive Disorder (MDD). The investigators hope to learn if this TMS treatment improves suicidal ideation over 10 days and clinical outcomes over 1 year of follow-up.

Interventions

  • DEVICE MagVenture TMS Therapy System w/Theta Burst Stimulation
  • DEVICE Sham MagVenture TMS Therapy System w/Theta Burst Stimulation

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-04-04
Est. Completion 2027-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04502758

The ClinicalTrials.gov registry entry for NCT04502758 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (79% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which MagVenture TMS Therapy System w/Theta Burst Stimulation is the first listed.

NCT04502758 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04502758 about?

NCT04502758 is a clinical study titled "Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents With Suicidal Ideation". The purpose of this study is to gather information regarding the use of a new type of transcranial magnetic stimulation (TMS) called theta burst stimulation (TBS) for suicidal ideation in adolescents with Major Depressive Disorder (MDD). The investigators hope to learn if this TMS treatment improves...

What is the current status of trial NCT04502758?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-04-04. Estimated completion is 2027-12.

What conditions does trial NCT04502758 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Suicidal Ideation.

What interventions are being tested in trial NCT04502758?

The interventions under investigation include: MagVenture TMS Therapy System w/Theta Burst Stimulation (DEVICE), Sham MagVenture TMS Therapy System w/Theta Burst Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04502758?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04502758 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.